While some experts define the term 'psychedelic' specifically as agonists of serotonin 2A receptors (such as psilocybin), psychedelic treatment models have been applied to diverse psychoactive drugs including MDMA, ibogaine, cannabis, and ketamine.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (6)

• ketamine concept
• psilocybin concept
• MDMA concept
• ibogaine concept
• psychedelic concept
• serotonin 2A receptor concept